1. Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma 
Enrico Derenzini, Vittorio Stefoni, Roberto Maglie, Beatrice Casadei, Cinzia Pellegrini, Alessandro Broccoli, Giulia Stefani, Stefano Fanti, Maria Rosa Motta, Riccardo Narducci, Lisa Argnani, Pier Luigi Zinzani 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 12, Pages (December 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
General study design. LVEF, left ventricular ejection fraction; PFT, pulmonary function test; PR, partial response.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
HSC collection algorithm in the RIT group. LVEF, left ventricular ejection fraction; CHEMO, chemotherapy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
(A) Impact of prior therapies (R-CHOP versus R-FM versus RIT) on the first PBSC mobilization attempt. (B) Impact of prior fludarabine versus R-CHOP exposure on the first PBSC mobilization attempt in the RIT group. (C) Impact of the number of prior therapies on the first PBSC mobilization attempt. *P < .05; **P < .01; ***P < .001.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
(A) Time to ANC (≥500/μL) and PLT recovery (≥20,000/μL) in the chemotherapy (CHT) group (n = 87) compared with the RIT group (n = 10). (B) Time to ANC (≥500/μL) and PLT recovery (≥20,000/μL) in patients reinfused with <2.0 × 106/kg CD34+ cells (n = 9) compared with patients reinfused with >2.0 × 106/kg CD34+ cells (total n = 88). (C) Time to ANC (≥500/μL) and PLT recovery (≥20,000/μL) in the chemotherapy (CHT) group (n = 81) compared with the RIT group (n = 7) for patients reinfused with >2.0 × 106/kg CD34+ cells (total n = 88).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions